trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['t-dxd', 'thanks', 'sarcoma']
. #asco23 highlight: in our interview, dr damon reed, , shed light on emerging strategies in osteosarcoma and ewing sarcoma, and told us all about a phase 2 study of t-dxd in adolescents and young adults with recurrent her2+ osteosarcoma. thanks for stopping by! 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.